Skip to main content
Erschienen in: Supportive Care in Cancer 11/2019

06.03.2019 | Original Article

Who will care for the caregiver? Distress and depression among spousal caregivers of older patients undergoing treatment for cancer

verfasst von: Gil Goldzweig, L. Schapira, L. Baider, J. M. Jacobs, E. Andritsch, Y. Rottenberg

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although it is accepted that in general spousal caregivers of patients with cancer are under high emotional and physical strain, little is known about the quality of life specifically among spousal caregivers of older cancer patients. The aim of the current study is to explore the emotional toll of spousal caregivers of cancer patients aged 65–85 years.

Methods

This study surveyed 242 spousal caregivers of patients ≥ 65 years old, diagnosed with cancer, treated with curative or palliative intent, and within 6 months of treatment at enrollment. Standardized measures completed by the caregivers included depression measure (Geriatric Depression Scale); distress (Distress Thermometer); and social support (the Cancer Perceived Agents of Social Support). Logistic regression analyses were used in order to identify the predictor of clinical depression and distress. The analyses were adjusted for patient (sociodemographic, functional performance, and medical status) and caregiver (sociodemographic and social support) factors.

Results

Among the caregivers, the frequencies of clinical depression and distress were 16.5% and 28% respectively. Increasing patient age and time from diagnosis were associated with reduced levels of caregiver depression. Higher levels of friends and spousal support (support from the patients) were associated with non-clinical levels of depression and distress.

Conclusion

Increasing patient age and caregiver’s perceived spousal support may both have a positive effect on caregivers’ levels of depression. This can be utilized by clinicians in the process of empowering older patients and their spousal caregivers to confront the challenges of cancer treatment into advanced old age.
Literatur
4.
Zurück zum Zitat Kent EE, Rowland JH, Northouse L, Litzelman K, Chou WYS, Shelburne N, Timura C, O'mara A, Huss K (2016) Caring for caregivers and patients: research and clinical priorities for informal cancer caregiving. Cancer 122(13):1987–1995CrossRefPubMed Kent EE, Rowland JH, Northouse L, Litzelman K, Chou WYS, Shelburne N, Timura C, O'mara A, Huss K (2016) Caring for caregivers and patients: research and clinical priorities for informal cancer caregiving. Cancer 122(13):1987–1995CrossRefPubMed
5.
Zurück zum Zitat Kim Y, Duberstein PR, Sörensen S, Larson MR (2005) Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support, and caregiving burden. Psychosomatics 46(2):123–130CrossRefPubMed Kim Y, Duberstein PR, Sörensen S, Larson MR (2005) Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support, and caregiving burden. Psychosomatics 46(2):123–130CrossRefPubMed
6.
Zurück zum Zitat Li Q, Mak Y, Loke A (2013) Spouses’ experience of caregiving for cancer patients: a literature review. Int Nurs Rev 60(2):178–187CrossRefPubMed Li Q, Mak Y, Loke A (2013) Spouses’ experience of caregiving for cancer patients: a literature review. Int Nurs Rev 60(2):178–187CrossRefPubMed
7.
Zurück zum Zitat Seal K, Murray CD, Seddon L (2015) The experience of being an informal “carer” for a person with cancer: a meta-synthesis of qualitative studies. Palliat Support Care 13(3):493–504CrossRefPubMed Seal K, Murray CD, Seddon L (2015) The experience of being an informal “carer” for a person with cancer: a meta-synthesis of qualitative studies. Palliat Support Care 13(3):493–504CrossRefPubMed
11.
Zurück zum Zitat Valeberg BT, & Grov EK (2013) Symptoms in the cancer patient–of importance for their caregivers' quality of life and mental health? Eur J Oncol Nurs 17(1):46–51 Valeberg BT, & Grov EK (2013) Symptoms in the cancer patient–of importance for their caregivers' quality of life and mental health? Eur J Oncol Nurs 17(1):46–51
15.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed
16.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
17.
Zurück zum Zitat Hoyl MT, Alessi CA, Harker JO, Josephson KR, Pietruszka FM, Koelfgen M, Mervis JR, Fitten LJ, Rubenstein LZ (1999) Development and testing of a five-item version of the Geriatric Depression Scale. J Am Geriatr Soc 47(7):873–878CrossRefPubMed Hoyl MT, Alessi CA, Harker JO, Josephson KR, Pietruszka FM, Koelfgen M, Mervis JR, Fitten LJ, Rubenstein LZ (1999) Development and testing of a five-item version of the Geriatric Depression Scale. J Am Geriatr Soc 47(7):873–878CrossRefPubMed
18.
Zurück zum Zitat Weeks SK, McGann PE, Michaels TK, & Penninx BW (2003) Comparing various short‐form Geriatric Depression Scales leads to the GDS‐5/15. J Nurs Scholarsh 35(2):133–137 Weeks SK, McGann PE, Michaels TK, & Penninx BW (2003) Comparing various short‐form Geriatric Depression Scales leads to the GDS‐5/15. J Nurs Scholarsh 35(2):133–137
19.
Zurück zum Zitat Zalsman G, Weizman A, Carel CA, Aizenberg D (2001) Geriatric Depression Scale (GDS-15): a sensitive and convenient instrument for measuring depression in young anorexic patients. J Nerv Ment Dis 189(5):338–339CrossRefPubMed Zalsman G, Weizman A, Carel CA, Aizenberg D (2001) Geriatric Depression Scale (GDS-15): a sensitive and convenient instrument for measuring depression in young anorexic patients. J Nerv Ment Dis 189(5):338–339CrossRefPubMed
23.
Zurück zum Zitat IBM_Corp R (2010) IBM SPSS statistics for windows (version 21.0)[computer program]. IBM Corp, Armonk IBM_Corp R (2010) IBM SPSS statistics for windows (version 21.0)[computer program]. IBM Corp, Armonk
Metadaten
Titel
Who will care for the caregiver? Distress and depression among spousal caregivers of older patients undergoing treatment for cancer
verfasst von
Gil Goldzweig
L. Schapira
L. Baider
J. M. Jacobs
E. Andritsch
Y. Rottenberg
Publikationsdatum
06.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04711-6

Weitere Artikel der Ausgabe 11/2019

Supportive Care in Cancer 11/2019 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.